Boudier, Ariane, 1981-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Ariane Boudier researcher
VIAF ID: 196196114 (Personal)
Permalink: http://viaf.org/viaf/196196114
Preferred Forms
4xx's: Alternate Name Forms (1)
5xx's: Related Names (2)
- 511 2 _
‡a
Laboratoire réactions et génie des procédés
- 511 2 _
‡a
Université de Lorraine (2012-....)
Works
| Title | Sources |
|---|---|
| Applications of Noble Metal Nanoclusters for Diagnostic andTargeting Cancer Therapy. |
|
| Design of surface ligands for blood compatible gold nanoparticles: Effect of charge and binding energy |
|
| Dextran-covered pH-sensitive oily core nanocapsules produced by interfacial Reversible Addition-Fragmentation chain transfer miniemulsion polymerization |
|
| Directive ICH Q3D : maîtrise des impuretés élémentaires potentiellement présentes dans les produits pharmaceutiques : application chez un sous-traitant pharmaceutique |
|
| Enhancement of the bioavailability of biopharmaceutical classification II active pharmaceutical ingredient the by enhancement of the dissolution rate : application to the paediatric population. |
|
| Fiches et QCM de chimie générale : [UE1, UE3, UE spé pharma] |
|
| Formulation of innovative biomaterials based on biomacromolecular complexes. |
|
| Guideline ICH Q3D : control of elemental impurities potentially present in pharmaceutical drug products : application by a contract manufacturing organization. |
|
| [Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest?] |
|
| Impact of tumor reoxgynenation by nanoparticles on tumors associated macrophages. |
|
| In situ formulations of nitric oxide donors. |
|
| Invasive capabilities of glioblastomas : interest of gold/gadolinium hybrid nanoparticles,alone or in combination with radiotherapy. |
|
| Long-lasting and controlled antioxidant property of immobilized gold nanoparticles for intelligent packaging |
|
| Micelles de copolymère à blocs double-hydrophiles pour des thérapies ex vivo par les cellules dendritiques |
|
| Nanoformulation of an antiretroviral drug for the targeting of HIV-1 reservoirs. |
|
| Nanotechnologies impact on medical devices. |
|
| Nouveaux biomatériaux saloplastiques basés sur des complexes de polyélectrolytes ultracentrifugés. |
|
| Physicochemical characterization of S-nitrosoglutathion, a compound with therapeutic potential in the cardiovascular field : Toward a monography setting. |
|
| Physicochemical optimization of functionalized films for cardiovascular applications. |
|
| Polyion complex micelles : vector synthesis for Ex Vivo dentritic cell therapy. |
|
| Polymeric films for innovative stent development. |
|
| Quality control of gold nanoparticles as pharmaceutical ingredients |
|
| Les risques liés à la production de médicaments injectables dérivés du plasma et leurs moyens de réduction |
|
| Rôle des altérations génomiques et épigénomiques dans les mécanismes moléculaires à l'origine des pathologies associées aux maladies rares du métabolisme de la vitamine B12 |
|
| Stability and degradation of medicines : interest of food-inspired nanostructured packaging. |
|
| Le sulfure d'hydrogène : propriétés physio-pharmacologiques et intérêt dans la neuroprotection post-arrêt cardiorespiratoire |
|
| Synthèse et caractérisation de nanoparticules d'or greffées par le glutathion réduit en vue de l'obtention de réservoirs d'oxyde nitrique |
|
| Synthesis and characterization of gold nanoparticles grafted with glutathione, as potential nitric oxide reservoirs. |
|
| Understanding the Thermodynamic Mechanisms Leading to the Binding of Albumin to Lipid Nanocapsules |
|
